AbCellera 
Welcome,         Profile    Billing    Logout  
  Products    Diseases    Trials    News 

Download options
                                                                                                      
 Phase 
N/A
1
2
3
4
 Trials
 02468101214161820
            
            
             
bamlanivimab (LY-CoV555) / Eli Lilly, AbCellera, National Institute of Allergy and Infectious Diseases           
          
            
             
bebtelovimab (LY-CoV1404) / AbCellera, Eli Lilly